MUCUS RELIEF
- Product NDC
- 68210-4102
- Requested package NDC
- 68210-4102-5
- 11-digit product format
- 682104102
- Labeler code
- 68210
- Product ID
- 68210-4102_d20605f5-58eb-6e61-e053-2a95a90a320b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- SPIRIT PHARMACEUTICALS LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2020-07-02
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68210-4102-1 | MUCUS RELIEF | 200 in 1 BOTTLE | TABLET | 200 | | 6 |
| 68210-4102-2 | MUCUS RELIEF | 50 in 1 PACKAGE | TABLET | 50 | | 6 |
| 68210-4102-5 | MUCUS RELIEF | 150 in 1 BOTTLE | TABLET | 150 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68210-4102 | MUCUS RELIEF (GUAIFENESIN) TABLET [SPIRIT PHARMACEUTICALS LLC] | 6 | Legacy NDC, 3 package rows | 20241215_d2ab3a1d-6b47-4b4e-b47a-eee79eac2a1e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68210-4102-5 | 68210410205 | 150 TABLET in 1 BOTTLE (68210-4102-5) | 150 tablet | 2020-10-07 | 0000-00-00 | No | No | Current |